Drug survival of adalimumab biosimilars in real-world treatment of psoriasis: A Spanish multicenter study

Anna López-Ferrer; Eva Vilarrasa; Susana Armesto; Jorge Santos-Juanes; Cristina Galache; Gregorio Carretero; Antonio Sahuquillo; Laura Salgado-Boquete; Elena Del Alcázar; Alvaro González-Cantero; Antonio Martorell; Raquel Rivera-Díaz; Josune Mitxelena-Ezeiza; Almudena Mateu; Isabel Belinchón; Mar Llamas-Velasco; Josep Riera-Monroig; Anna Lázaro; José Luis López-Estebaranz; Ignasi Gich; Lluis Puig

doi:10.1111/dth.15831

Drug survival of adalimumab biosimilars in real-world treatment of psoriasis: A Spanish multicenter study

Dermatol Ther. 2022 Nov;35(11):e15831. doi: 10.1111/dth.15831. Epub 2022 Sep 27.

Authors

Anna López-Ferrer¹, Eva Vilarrasa¹, Susana Armesto², Jorge Santos-Juanes³, Cristina Galache³, Gregorio Carretero⁴, Antonio Sahuquillo⁵, Laura Salgado-Boquete⁶, Elena Del Alcázar⁷, Alvaro González-Cantero⁸, Antonio Martorell⁹, Raquel Rivera-Díaz¹⁰, Josune Mitxelena-Ezeiza¹¹, Almudena Mateu¹², Isabel Belinchón¹³, Mar Llamas-Velasco¹⁴, Josep Riera-Monroig¹⁵, Anna Lázaro¹⁶, José Luis López-Estebaranz¹⁷, Ignasi Gich¹⁸, Lluis Puig¹

Affiliations

¹ Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
² Department of Dermatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
³ Deparment of Dermatology, Hospital Universitario Central de Asturias, Oviedo, Spain.
⁴ Department of Dermatology, Hospital Universitario de Gran Canaria Doctor Negrin, Las Palmas de Gran Canaria, Spain.
⁵ Department of Dermatology, Hospital Universitario y Politécnico La Fe de Valencia, Spain.
⁶ Department of Dermatology, Complexo Hospitalario Universitario de Pontevedra, Pontevedra, Spain.
⁷ Department of Dermatology, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain.
⁸ Department of Dermatology, Hospital Universitario Ramon y Cajal, Madrid, Spain.
⁹ Department of Dermatology, Hospital de Manises, Manises, Spain.
¹⁰ Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain.
¹¹ Department of Dermatology, Complejo Hospitalario de Navarra, Pamplona, Spain.
¹² Department of Dermatology, Hospital Universitario Doctor Peset, Valencia, Spain.
¹³ Department of Dermatology, Hospital General Universitario de Alicante, Alicante, Spain.
¹⁴ Department of Dermatology, Hospital la Princesa, Madrid, Spain.
¹⁵ Department of Dermatology, Hospital Clínic de Barcelona, Barcelona, Spain.
¹⁶ Department of Dermatology, Hospital Universitari Sagrat Cor, Barcelona, Spain.
¹⁷ Department of Dermatology, Hospital Universitario Fundación Alcorcón, Alcorcón, Spain.
¹⁸ Department of Epidemiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

PMID: 36109488
DOI: 10.1111/dth.15831

No abstract available

Publication types

Multicenter Study
Letter

MeSH terms

Adalimumab / therapeutic use
Biosimilar Pharmaceuticals* / therapeutic use
Etanercept / therapeutic use
Humans
Infliximab / therapeutic use
Psoriasis* / drug therapy

Substances

Adalimumab
Biosimilar Pharmaceuticals
Infliximab
Etanercept